MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, ANIK had $322K increase in cash & cash equivalents over the period. $4,362K in free cash flow.

Cash Flow Overview

Change in Cash
$322K
Free Cash flow
$4,362K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Stock-based compensation expense
    • Provision for inventory
    • Depreciation
    • Others
Negative Cash Flow Breakdown
    • Net loss
    • Repurchases of common stock
    • Purchases of property and equipm...
    • Others

Cash Flow
2025-12-31
Net loss
-10,880
Depreciation
5,372
Amortization of acquisition related intangible assets
357
Non-cash operating lease cost
2,061
(gain) loss on sale of assets
166
Loss on impairment of long-lived assets
0
Stock-based compensation expense
10,084
Deferred income taxes
-7
Provision for doubtful accounts
265
Provision for inventory
5,821
Interest income on notes receivable
896
Accounts receivable
-408
Inventories
-30
Prepaid expenses, other current and long-term assets
-2,327
Accounts payable
42
Operating lease liabilities
-1,996
Accrued expenses, other current and long-term liabilities
-1,500
Income taxes
-134
Net cash provided by (used in) operating activities
11,188
Purchases of property and equipment
6,826
Proceeds from sale of parcus
4,496
Notes receivable
1,329
Proceeds from sale of intangible assets
600
Acquisition of intangible asset
0
Net cash used in investing activities
-401
Repurchases of common stock
9,485
Proceeds from employee stock purchase program
500
Cash paid for tax withheld on vested restricted stock awards
1,566
Proceeds from exercises of equity awards
0
Net cash used in financing activities
-10,551
Exchange rate impact on cash
86
Decrease in cash and cash equivalents
322
Cash and cash equivalents at beginning of period
57,159
Cash and cash equivalents at end of period
57,481
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Stock-based compensationexpense$10,084K Provision for inventory$5,821K Depreciation$5,372K Prepaid expenses, othercurrent and long-term...-$2,327K Non-cash operating leasecost$2,061K Accounts receivable-$408K Amortization of acquisitionrelated intangible...$357K Provision for doubtfulaccounts$265K Accounts payable$42K Inventories-$30K Net cash provided by(used in) operating...$11,188K Exchange rate impact oncash$86K Canceled cashflow$15,579K Decrease in cash and cashequivalents$322K Canceled cashflow$10,952K Net loss-$10,880K Operating leaseliabilities-$1,996K Accrued expenses, othercurrent and long-term...-$1,500K Interest income on notesreceivable$896K (gain) loss on sale ofassets$166K Income taxes-$134K Deferred income taxes-$7K Proceeds from employeestock purchase...$500K Proceeds from sale ofparcus$4,496K Notes receivable$1,329K Proceeds from sale ofintangible assets$600K Net cash used infinancing activities-$10,551K Net cash used ininvesting activities-$401K Canceled cashflow$500K Canceled cashflow$6,425K Repurchases of common stock$9,485K Cash paid for taxwithheld on vested...$1,566K Purchases of property andequipment$6,826K

Anika Therapeutics, Inc. (ANIK)

Anika Therapeutics, Inc. (ANIK)